EU Says J&J, Novartis Pay-For-Delay Breached Antitrust Laws
European antitrust regulators said Thursday they believed drugmakers Johnson & Johnson and Novartis AG violated European competition law by inking an agreement to delay the launch of cheaper generic drugs in...To view the full article, register now.
Already a subscriber? Click here to view full article